the following bits jumped out at me:
"With a typical 20-year lifeof a new vaccine, and other vaccines planned, we see this as a highly prospective profitable strategicpartnership for AnteoTech". If the vaccine maker uses Anteobind as part of their formulation approved by regulatory authorites then they would have to continue to use Anteobind. This was the paraphrased message in one of Davids presentations. Lets hope the minimum deal is going to be just that and only grow with SI's growing use case and use volumes for Anteobind.
"In parallel, EV1 has advised that they will be accelerating their assessment of highersilicon anodes (>20%) and they expect to purchase some proprietary high silicon anodes fromAnteoTech in 1H FY25." Hope they buy lots and lots and lots.
No mention of Wyon? If Trinseo is dead in the water then Wyon makes it a case of no news is good news?
the following bits jumped out at me:"With a typical 20-year...
Add ADO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $67.22M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 370325 | 2.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.4¢ | 31036 | 1 |
View Market Depth
| Last trade - 16.12pm 12/11/2024 (20 minute delay) ? |
| ADO (ASX) Chart |
Day chart unavailable